Search - tctmd.com

Displaying 281 - 300 of 567

Sort: Relevancy | Date

News Daily News

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

Michael O'Riordan

November 29, 2019

News Daily News

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

Michael O'Riordan

November 11, 2019

News Daily News

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Michael O'Riordan

November 05, 2019

News Daily News

STEMI Mortality Unaffected by Weekend, Weeknight, or Holiday Admission in France

Michael O'Riordan

October 31, 2019

News Daily News

Repeat Target-Lesion PCI: An Option for Public Reporting?

Michael O'Riordan

October 25, 2019

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Daily News

DAPT Cuts Saphenous Vein Graft Failure After CABG: Meta-analysis

Michael O'Riordan

October 17, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Daily News

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Michael O'Riordan

October 09, 2019

News Daily News

FDA: Class I Recall for Medtronic’s 6-Fr Sherpa NX Guide Catheter

Michael O'Riordan

October 09, 2019

News Conference News

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Michael O'Riordan

October 07, 2019

News Conference News TCT 2019

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Michael O'Riordan

October 03, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

News Conference News ESC 2019

Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT

Michael O'Riordan

September 03, 2019

News Conference News ESC 2019

Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS

Michael O'Riordan

September 01, 2019

News Conference News ESC 2019

POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients

Michael O'Riordan

August 31, 2019

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

News Daily News

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

Michael O'Riordan

August 22, 2019

News Daily News

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Michael O'Riordan

August 14, 2019

Advertisement

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

STEMI Mortality Unaffected by Weekend, Weeknight, or Holiday Admission in France

Repeat Target-Lesion PCI: An Option for Public Reporting?

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

DAPT Cuts Saphenous Vein Graft Failure After CABG: Meta-analysis

Recurrent Events Common Among Young Patients With CAD

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

FDA: Class I Recall for Medtronic’s 6-Fr Sherpa NX Guide Catheter

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Tailored Hydration Strategy Cuts Contrast-Induced Kidney Injury: REMEDIAL III

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT

Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS

POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients

More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content